MedTrace Logo

Effectiveness and Safety of Probiotics in Relieving Anxiety and Depression

NCT06629441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-08-19

No results posted yet for this study

Summary

To evaluate the effectiveness and safety of probiotics in relieving anxiety and depression in adults, in comparison with placebo.

Conditions

  • Anxiety Depression

Interventions

DIETARY_SUPPLEMENT

Probiotic group

taking 10 billion CFU probiotic one sachet one time, lasting 56 days.

DIETARY_SUPPLEMENT

Placebo group

taking maltodaxtrin one sachet one time, lasting 56 days.

Sponsors & Collaborators

  • Wecare Probiotics Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-20
Primary Completion
2024-12-15
Completion
2025-01-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06629441 on ClinicalTrials.gov